| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Elicio Therapeutics, Inc
13G/A
ELTX · 28657F103
|
5.3% |
7/8/2026
Event 7/1/2026
|
||||
| Knoll Capital Management, LLC | 5.3% | |||||
| Fred Knoll | 5.3% | |||||
| Gakasa Holdings, LLC | 5.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.